X0306 4 2019-06-07 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001778051 Shreedhar Vijay C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 0 1 0 0 Chief Commercial Officer Common Stock 2019-06-07 4 A 0 68750 0.00 A 68750 D Stock Option (Right to Buy) 4.67 2019-06-07 4 A 0 137500 0.00 A 2029-06-06 Common Stock 137500 137500 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of June 20, 2020, June 20, 2021, June 20, 2022 and June 20, 2023, subject to Reporting Person's Continuous Service as of each such date. The Option shares shall vest as follows: 25% of the shares subject to the option shall vest on May 29, 2020 and an additional 1/48th of the shares subject to the option shall vest on a monthly basis thereafter over the following 36 months. /s/ Alfred Merriweather, Attorney-in-fact 2019-06-07